Kymera Therapeutics Inc (KYMR)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 11.51M | 9.55M | 16.14M | 9.47M | 16.51M | 4.73M | 47.89M | 10.29M |
| Operating Income | -40.81M | -44.88M | -38.63M | -45.33M | -43.38M | -57.51M | -19.31M | -52.91M |
| Pre Tax Income | -40.26M | -43M | -34.87M | -40.93M | -38.8M | -52.87M | -14.37M | -48.56M |
| Net Income | -40.26M | -43M | -34.87M | -40.93M | -38.8M | -52.87M | -14.37M | -48.56M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -40.81M | -44.88M | -38.63M | -45.33M | -43.38M | -57.51M | -19.31M | -52.91M |
| EBITDA | -40.11M | -44.07M | -37.85M | -44.45M | -42.48M | -55.49M | -19.55M | -51.45M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 2.93M | 34.03M | 72.83M | 46.83M | 78.59M |
| Operating Income | -21.45M | -42.21M | -46.3M | -100.53M | -161.26M | -165.53M |
| Pre Tax Income | -21.47M | -41.25M | -45.59M | -100.22M | -154.81M | -146.96M |
| Net Income | -21.47M | -41.25M | -54.64M | -100.22M | -154.81M | -146.96M |
| Preferred Dividends | 0 | 0 | -9.05M | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -9.1 | -13.405 | -1.219 | -1.945 | -2.813 | -2.649 |
| EBIT | -21.45M | -42.21M | -46.3M | -100.53M | -161.26M | -165.53M |
| EBITDA | -21.25M | -41.38M | -44.54M | -98.13M | -158.28M | -161.97M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
